Deutsche Bank Ag\ Unity Biotechnology, Inc. Transaction History

Deutsche Bank Ag\

$218 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.3 - $3.17 $218,605 - $533,060	-168,158 Closed	0 $0
Q3 2021 Nov 04, 2021	SELL	$2.91 - $4.5 $261,341 - $404,136	-89,808 Reduced 34.81%	168,158 $504,000
Q2 2021 Aug 11, 2021	BUY	$4.15 - $6.3 $958,774 - $1.46 Million	231,030 Added 857.7%	257,966 $1.2 Million
Q1 2021 May 13, 2021	BUY	$5.51 - $9.42 $2,457 - $4,201	446 Added 1.68%	26,936 $161,000
Q4 2020 Feb 16, 2021	BUY	$3.42 - $6.36 $27,578 - $51,287	8,064 Added 43.76%	26,490 $139,000
Q3 2020 Nov 12, 2020	BUY	$2.94 - $12.43 $832 - $3,517	283 Added 1.56%	18,426 $64,000
Q2 2020 Aug 13, 2020	BUY	$5.28 - $9.67 $45,276 - $82,920	8,575 Added 89.62%	18,143 $157,000
Q1 2020 May 14, 2020	SELL	$5.0 - $7.6 $2,880 - $4,377	-576 Reduced 5.68%	9,568 $55,000
Q4 2019 Feb 14, 2020	BUY	$5.99 - $8.38 $17,125 - $23,958	2,859 Added 39.25%	10,144 $73,000
Q3 2019 Nov 14, 2019	SELL	$5.62 - $9.63 $4,372 - $7,492	-778 Reduced 9.65%	7,285 $43,000
Q2 2019 Aug 14, 2019	SELL	$7.59 - $10.21 $159,678 - $214,797	-21,038 Reduced 72.29%	8,063 $75,000
Q1 2019 May 15, 2019	BUY	$7.65 - $16.66 $4,000 - $8,713	523 Added 1.83%	29,101 $234,000
Q4 2018 Feb 14, 2019	BUY	$10.76 - $17.25 $184,555 - $295,872	17,152 Added 150.11%	28,578 $464,000
Q3 2018 Dec 21, 2021	BUY	$14.34 - $22.97 $19,014 - $30,458	1,326 Added 13.13%	11,426 $186,000
Q3 2018 Nov 14, 2018	BUY	$14.34 - $22.97 $6,037 - $9,670	421 Added 4.35%	10,100 $164,000
Q2 2018 Apr 21, 2020	BUY	$12.76 - $16.94 $20,900 - $27,747	1,638 Added 20.37%	9,679 $145,000
Q2 2018 Aug 14, 2018	BUY	$12.76 - $16.94 $102,603 - $136,214	8,041 New	8,041 $120,000

Others Institutions Holding UBX

# of Institutions

Shares Held

4.41M

Call Options Held

Put Options Held

Empery Asset Management, LP New York, NY

4.41M
Shares

$6.49 Million
10.37% of portfolio

View Full List

About Unity Biotechnology, Inc.

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $20.6M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

More about UBX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account